SEO report of pharmaceutical-technology.com

Pharmaceutical Technology

www.pharmaceutical-technology.com/

Pharmaceutical Technology is a procurement and reference site providing a one-stop-shop for professionals and decision makers within the global ...


 Tasks

  • Avoid using deprecated HTML tags.
  • Implement the viewport meta tag.

 SEO

URL

Domain : www.pharmaceutical-technology.com/

Character length : 34

Title
Pharmaceutical Technology
Description
Pharmaceutical Technology is a procurement and reference site providing a one-stop-shop for professionals and decision makers within the global Pharmaceutical industry
Keywords (meta keywords)
Good! The website does not use “meta keywords”.
Open Graph Protocol

Error! The website does not use the OG (Open Graph) protocol.

Dublin Core
Dublin Core is in use
Underscores in the URLs
Error! Hyphen (-) is a better solution than underscore (_) in the URLs
Search engine friendly URLs
Good! The website uses SEO friendly URLs.
Checking the robots.txt file
There is robots.txt file.
https://pharmaceutical-technology.com/robots.txt
User-agentDisallowed for the search engines
*
  • /search
  • /Search
  • /*WT.mc_id=*
  • /*WT.MC_ID=*
  • /*wt.mc_id=*
  • /*wt.MC_ID=*


 Social

Social Engagement

Linkedin46

Facebook Share0

Facebook Comments0

 Content

Doctype
HTML 5
Encoding
Perfect! The character encoding is set: UTF-8.
Language
Error! No language localization is found.
Title
Pharmaceutical Technology

Character length : 25

Good! The title’s length is between 10 and 70 characters.
Text / HTML ratio
Ratio : 20%

Acceptable! The text / code ratio is between 15 and 25 percent.
Headings
H1H2H3H4H5H6
43817010600
Heading structure in the source code
  • <H2> Drug Development
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H3> Analysis
  • <H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H3> Analysis
  • <H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
  • <H3> Analysis
  • <H4> Challenging the link between pharma innovation and US drug pricing
  • <H2> Clinical Trials
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
  • <H3> Analysis
  • <H4> Challenging the link between pharma innovation and US drug pricing
  • <H3> Comments
  • <H4> PCR-based C. difficile Cytotoxin assays alone not appropriate for pivotal endpoint measures
  • <H3> Analysis
  • <H4> Cancergraph: a desperately needed link between patient and clinical trial
  • <H2> Manufacturing
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H3> Analysis
  • <H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H3> Analysis
  • <H4> Crowdfunding for cancer therapy
  • <H3> Analysis
  • <H4> Pharmaceutical packaging: where should drug companies focus their efforts?
  • <H2> Packaging
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Pharmaceutical packaging: where should drug companies focus their efforts?
  • <H3> Suppliers
  • <H4> Aptar Pharma - Setting the Standard for Drug Delivery
  • <H3> Analysis
  • <H4> Taking the sting out of painkillers: how close are we to ending the opiate epidemic?
  • <H3> Analysis
  • <H4> Pharma Technology Focus – Issue 50
  • <H2> Cold Chain
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Brain boosters: exploring the grey area of off-label ‘smart drugs’
  • <H3> Analysis
  • <H4> India's drug price overhaul: a question of balance
  • <H3> Analysis
  • <H4> Pfizer’s big antibiotic buyout: a sign of things to come?
  • <H3> Analysis
  • <H4> Taking the sting out of painkillers: how close are we to ending the opiate epidemic?
  • <H2> Diseases
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Crowdfunding for cancer therapy
  • <H3> Comments
  • <H4> More than just a pretty face: Botox set to combat depression
  • <H3> Comments
  • <H4> Curing hepatitis C: A double-edged sword for liver transplant candidates?
  • <H3> Comments
  • <H4> Small but mighty: nanotechnology in cancer therapy
  • <H2> Market Data
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H3> Analysis
  • <H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H3> Analysis
  • <H4> Challenging the link between pharma innovation and US drug pricing
  • <H3> Analysis
  • <H4> Brain boosters: exploring the grey area of off-label ‘smart drugs’
  • <H2> Technology
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> News »
  • <H3> Suppliers »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Analysis
  • <H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
  • <H3> Analysis
  • <H4> Narrowing the hunt for nanoparticles
  • <H3> Comments
  • <H4> Small but mighty: nanotechnology in cancer therapy
  • <H3> Projects
  • <H4> Michael Uren Biomedical Engineering Research Hub, London
  • <H2> Companies
  • <H3> Company A-Z »
  • <H3> Products & Services »
  • <H3> Press Releases »
  • <H3> White Papers »
  • <H3> Videos »
  • <H3> Suppliers
  • <H4> Cellular Technology Limited (CTL) - Contact Laboratory Services Provider
  • <H3> Suppliers
  • <H4> Plastiape Group - Medical Devices and Packaging Solutions for the Pharmaceutical Industry
  • <H3> Suppliers
  • <H4> TechTrak - Contaminant Control Flooring for Cleanroom Environments
  • <H3> Suppliers
  • <H4> Molnár-Institute - HPLC Method Development Software for the Pharmaceutical Industry
  • <H2> All Sections
  • <H3> Projects »
  • <H3> Analysis »
  • <H3> Company A-Z »
  • <H3> Products & Services »
  • <H3> News »
  • <H3> Press Releases »
  • <H3> White Papers »
  • <H3> Comment »
  • <H3> Research Reports »
  • <H3> Advertise With Us »
  • <H3> Report Store »
  • <H3> About us »
  • <H2> Today's Top Stories
  • <H1> Are cheap Canadian drugs a solution to US pricing issues?
  • <H1> AGORA Cancer Centre, Lausanne
  • <H1> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H1> European Molecular Biology Laboratory Site, Barcelona
  • <H3> Headlines
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H4> AGORA Cancer Centre, Lausanne
  • <H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H4> European Molecular Biology Laboratory Site, Barcelona
  • <H2> Hot Topics
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
  • <H4> Challenging the link between pharma innovation and US drug pricing
  • <H2> Comment & Analysis »
  • <H2> Aerie’s ophthalmic candidate succeeds in registration trial
  • <H2> Increased risk of amputation if taking type 2 diabetes drug Invokana
  • <H2> Transferring technology: from concept to commercialisation
  • <H2> Are cheap Canadian drugs a solution to US pricing issues?
  • <H2> New treatments will soon be available for long-neglected NASH sufferers
  • <H2> Company Releases »
  • <H2> Flexible, Accessible, Valuable, and Effective Imaging Solutions
  • <H2> Efficient Synthesis Development
  • <H2> Klocke uses NA and ML for Quality Storage
  • <H2> VeriPac UBV Universal Blister Verification
  • <H2> Child Safe Packaging Today
  • <H2> Pharmaceutical Insights »
  • <H3> Are cheap Canadian drugs a solution to US pricing issues?
  • <H3> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H3> Crowdfunding for cancer therapy
  • <H2> Pharmaceutical Industry Reports »
  • <H4> Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space
  • <H4> EMA set to approve plethora of oncology drugs
  • <H4> Oncology remains top orphan drug designation choice for companies after 5 years
  • <H4> Top indications and therapy areas for 2012-2016 clinical trials in Israel
  • <H2> Drug Development »
  • <H3> Suppliers
  • <H4> Cellular Technology Limited (CTL) - Contact Laboratory Services Provider
  • <H3> Comments
  • <H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
  • <H3> Analysis
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H3> Comments
  • <H4> New drug class set to reduce migraine misery
  • <H3> Comments
  • <H4> Pipeline biosimilar surge in emerging markets
  • <H3> Comments
  • <H4> Can DAA treatment increase the risk of HCC? Emerging data points towards ‘no’
  • <H2> Clinical Trials »
  • <H3> Suppliers
  • <H4> Cellular Technology Limited (CTL) - Contact Laboratory Services Provider
  • <H3> Comments
  • <H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
  • <H3> Suppliers
  • <H4> Molnár-Institute - HPLC Method Development Software for the Pharmaceutical Industry
  • <H3> Suppliers
  • <H4> Topstone Research - Clinical Trial Management
  • <H3> Comments
  • <H4> Transferring technology: from concept to commercialisation
  • <H3> Comments
  • <H4> New treatments will soon be available for long-neglected NASH sufferers
  • <H2> Manufacturing »
  • <H3> Suppliers
  • <H4> Plastiape Group - Medical Devices and Packaging Solutions for the Pharmaceutical Industry
  • <H3> Suppliers
  • <H4> TechTrak - Contaminant Control Flooring for Cleanroom Environments
  • <H3> Suppliers
  • <H4> LTE Scientific - Autoclaves and Thermal Equipment for the Medical Industry
  • <H3> Analysis
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H3> Suppliers
  • <H4> Priorclave - Autoclaves and Sterilisation Equipment
  • <H3> Suppliers
  • <H4> Quality Assurance Management (QAM) - Inspection and Analytical Services for the Pharmaceutical Industry
  • <H2> Packaging »
  • <H3> Suppliers
  • <H4> Plastiape Group - Medical Devices and Packaging Solutions for the Pharmaceutical Industry
  • <H3> Projects
  • <H4> AstraZeneca R&D Centre and Corporate Headquarters, Cambridge
  • <H3> Suppliers
  • <H4> Skrivanek - Medeical and Pharmaceutical Translation Services for Packaging, Clinical Trials, and Regulatory Documentation
  • <H3> Suppliers
  • <H4> Lablabo - Airless Metering Pumps for the Pharmaceutical Industry
  • <H3> Projects
  • <H4> Biosciences Partnership Building, Phoenix
  • <H3> Analysis
  • <H4> Pharma Technology Focus – Issue 58
  • <H2> Cold Chain »
  • <H3> Suppliers
  • <H4> O&S Shipping - Freight Forwarding Solutions for Pharmaceuticals
  • <H3> Comments
  • <H4> Seikagaku inks deal with Ono Pharmaceutical, strengthening its position in the Osteoarthritis market
  • <H3> Analysis
  • <H4> Brain boosters: exploring the grey area of off-label ‘smart drugs’
  • <H3> Projects
  • <H4> AstraZeneca R&D Centre and Corporate Headquarters, Cambridge
  • <H3> Suppliers
  • <H4> Lablabo - Airless Metering Pumps for the Pharmaceutical Industry
  • <H3> Suppliers
  • <H4> Munters - High-Quality Air Treatment Solutions for Pharma Production
  • <H2> Diseases »
  • <H3> Comments
  • <H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
  • <H3> Suppliers
  • <H4> Topstone Research - Clinical Trial Management
  • <H3> Projects
  • <H4> AGORA Cancer Centre, Lausanne
  • <H3> Comments
  • <H4> Roundup of Key Oncology Strategic Alliances in Q1 2017
  • <H3> Comments
  • <H4> New drug class set to reduce migraine misery
  • <H3> Comments
  • <H4> Highlights from the 2017 ATS Conference
  • <H2> Market Data »
  • <H3> Comments
  • <H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
  • <H3> Analysis
  • <H4> Are cheap Canadian drugs a solution to US pricing issues?
  • <H3> Comments
  • <H4> Highlights from the 2017 ATS Conference: positive results for AstraZeneca’s Daliresp beyond reducing the risk of exacerbations
  • <H3> Comments
  • <H4> Pacific Biosciences: don’t count them out yet
  • <H3> Analysis
  • <H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
  • <H3> Analysis
  • <H4> Challenging the link between pharma innovation and US drug pricing
  • <H2> Technology »
  • <H3> Suppliers
  • <H4> TechTrak - Contaminant Control Flooring for Cleanroom Environments
  • <H3> Suppliers
  • <H4> Molnár-Institute - HPLC Method Development Software for the Pharmaceutical Industry
  • <H3> Comments
  • <H4> Transferring technology: from concept to commercialisation
  • <H3> Suppliers
  • <H4> LTE Scientific - Autoclaves and Thermal Equipment for the Medical Industry
  • <H3> Comments
  • <H4> New treatments will soon be available for long-neglected NASH sufferers
  • <H3> Suppliers
  • <H4> O&S Shipping - Freight Forwarding Solutions for Pharmaceuticals
  • <H2> Follow Us
  • <H2> Newsletter
  • <H2> Latest News »
  • <H4> Deals this week: Inthera Bioscience, i2 Pharmaceuticals, InventisBio
  • <H4> M&As this week: Inspyr Therapeutics, Nissui Pharmaceutical
  • <H4> Chiltern buys IDA to integrate Japan and Asia into global drug development
  • <H4> Pfizer receives EC approval for Trumenba to prevent MenB disease in adolescents and young adults
  • <H4> Report shows research collaboration between UK and EU strengthens medical co-operation
  • <H2> Companies »
  • <H4> Cellular Technology Limited (CTL)
  • <H4> Plastiape Group
  • <H4> Topstone Research
  • <H4> TechTrak
  • <H4> Molnár-Institute
  • <H3> Follow us:
Word cloud
  • drug45
  • analysis44
  • suppliers34
  • pharmaceutical32
  • pricing30
  • clinical27
  • industry25
  • trial24
  • drugs23
  • comments22
  • issues20
  • solution20
  • canadian19
  • cheap19
  • new18
  • technology18
  • pharma18
  • packaging17
  • projects17
  • stem16
  • bluerock16
  • research16
  • cell15
  • contender15
  • petri15
  • dish15
  • journey15
  • canada’s15
  • cancer15
  • news13
  • therapy13
  • between13
  • solutions12
  • link12
  • development11
  • papers11
  • white11
  • innovation10
  • taking10
  • services10
  • delivery10
  • challenging10
  • reports10
  • comment10
  • videos10
  • companies9
  • disease9
  • risk9
  • medical9
  • possibilities8
  • laboratory8
  • detection8
  • focus8
  • set8
  • nanotech8
  • offers8
  • micro-machines8
  • oncology7
  • centre7
  • crowdfunding7
Keyword matrix
wordtitledescriptionsheading
drug
analysis
suppliers
pharmaceutical
pricing
clinical
Two Word cloud
  • stem cell11
  • pharmaceutical industry11
  • cheap canadian11
  • canadian drugs10
  • pricing issues9
  • canada’s stem9
Three Word cloud
  • journey from petri15
  • are cheap canadian11
  • canada’s stem cell9
  • stem cell contender6
  • link between pharma6
  • clinical trial analysis5
404 Page
The website has a 404 error page.
Flash content
Good! The website does not have any flash contents.
Frame
Good! The website does not use iFrame solutions.
Images
We found 37 images on this web page.

Alternate attributes for the following 36 images are missing. Search engines use "alt" tags to understand image content efficiently. We strongly recommend fixing this issue.

 Technologies

Mobile optimization
This website is optimal for mobile devices!
Deprecated HTML elements
Good! No deprecated HTML tags are detected.
Redirection (www / not www)
Good! The web address is accessible only in one version. The version without www is redirected to the version with www.
Deprecated HTML elements
Good! No deprecated HTML tags are detected.
Printability
Good! The website uses printer-friendly CSS.
Meta Tag (viewport tag, mobile devices)
Error! The meta tag named viewport is missing.

 Speed test

Server response time
The server response time is fast enough.
Loading time
4,395 ms
Table layout
Good! No nested tables found.
Render blocking resources
Good! No render blocking elements found!

 Speed test – Javascript

Javascript
Error! Too many javascript files found which slows down the page load on the website.
  • http://www.pharmaceutical-technology.com/scripts/jquery-1.4.1.min.js
  • http://www.pharmaceutical-technology.com/content/jquery/jquery.tools.min.js
  • http://www.pharmaceutical-technology.com/scripts/jquery.validate.js
  • http://www.pharmaceutical-technology.com/scripts/xval.jquery.validate.js
  • http://www.pharmaceutical-technology.com/scripts/pmg.customvalidators.js
  • http://www.pharmaceutical-technology.com/content/jquery/jquery.jalert.js
  • http://www.pharmaceutical-technology.com/content/js/kgi-master-head.min.js
  • http://www.pharmaceutical-technology.com/content/scripts/slick/slick.min.js
  • http://www.pharmaceutical-technology.com/scripts/pharmaceutical.sdc.js
  • http://www.pharmaceutical-technology.com/content/js/kgi-master.min.js
File size of all javascript files combined
0.00
Javascript minifying
Great! The Javascript files are minified.

 Speed test – CSS

CSS
Error! Too many CSS files detected that slows down the page load.
  • http://www.pharmaceutical-technology.com/content/font-awesome.css
  • http://www.pharmaceutical-technology.com/content/final_css_print.min.css
  • http://www.pharmaceutical-technology.com/content/css/jquery_ui_datepicker.css
  • http://www.pharmaceutical-technology.com/content/css/jalert.css
  • http://www.pharmaceutical-technology.com/content/kgi-master.min.css
  • http://www.pharmaceutical-technology.com/content/technology-theme.min.css
File size of all css files combined
0.00
CSS minifying
Great! The CSS elements are minified.

 Speed test – Compression

Uncompressed size of the of the HTML
0.00
Gzip compression
Your site uses compression.

 Speed test – Browser cache

Browser cache
The browser cache is set correctly for all elements.

 Speed test – Images

File size of all images combined
0.00
Image optimisation
All images are optimized.

 Traffic

Alexa
409320

 Links

We found a total of 239 different links.
Internal links: 230
External links: 9

External links:

Internal links:

Link text (anchor) Link strength

 Website security

IP
217.147.67.97
External hidden links
Good! No hidden external links found
Looking for eval()
Good! No eval(bas64_decode()) scripts are found
Checking for XSS vulnerability
No XSS vulnerability found
Email encryption
Good! We have not found any unencrypted email addresses.

 Sites on same ip

chemicals-technology.com

chemicals-technology.com

hydrocarbons-technology.com

hydrocarbons-technology.com

the-financedirector.com

the-financedirector.com

banking-gateway.com

banking-gateway.com

medicaldevice-network.com

medicaldevice-network.com

hospitalmanagement.net

hospitalmanagement.net

foodprocessing-technology.com

foodprocessing-technology.com

pharmaceutical-technology.com

pharmaceutical-technology.com

airforce-technology.com

airforce-technology.com

railway-technology.com

railway-technology.com

 Icons

Favicon
Good! The website uses favicon.

 Order of Heading elements on mobile by position

  • H2 : Drug Development, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Counting the cost of failure in drug development, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer, ( 0px from top )
  • H2 : Clinical Trials, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Counting the cost of failure in drug development, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Loss of exclusivity to limit J&J gain after Zytiga label extension, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer, ( 0px from top )
  • H2 : Manufacturing, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Are cheap Canadian drugs a solution to US pricing issues?, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Crowdfunding for cancer therapy, ( 0px from top )
  • H3 : Projects, ( 0px from top )
  • H4 : Michael Uren Biomedical Engineering Research Hub, London, ( 0px from top )
  • H2 : Packaging, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Pharmaceutical packaging: where should drug companies focus their efforts?, ( 0px from top )
  • H3 : Suppliers, ( 0px from top )
  • H4 : Aptar Pharma - Setting the Standard for Drug Delivery, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Taking the sting out of painkillers: how close are we to ending the opiate epidemic?, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Pharma Technology Focus – Issue 50, ( 0px from top )
  • H2 : Cold Chain, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Suppliers, ( 0px from top )
  • H4 : Labworks International Inc. - Environment Controlled Rooms, Cleanrooms, ICH Stability Chambers, Freezers, and Coolers for Temperature-Sensitive Pharmaceutical and Medical Products, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Brain boosters: exploring the grey area of off-label ‘smart drugs’, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : India's drug price overhaul: a question of balance, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Pfizer’s big antibiotic buyout: a sign of things to come?, ( 0px from top )
  • H2 : Diseases, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Loss of exclusivity to limit J&J gain after Zytiga label extension, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer, ( 0px from top )
  • H2 : Market Data, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Loss of exclusivity to limit J&J gain after Zytiga label extension, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
  • H3 : Comments, ( 0px from top )
  • H4 : Poor tolerability of Opdivo + Yervoy in frontline NSCLC could be Achilles heel, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Pooling resources for clinical trials, ( 0px from top )
  • H2 : Technology, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Suppliers », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Suppliers, ( 0px from top )
  • H4 : Labworks International Inc. - Environment Controlled Rooms, Cleanrooms, ICH Stability Chambers, Freezers, and Coolers for Temperature-Sensitive Pharmaceutical and Medical Products, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Counting the cost of failure in drug development, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Micro-machines: nanotech offers new possibilities for disease detection and drug delivery, ( 0px from top )
  • H3 : Analysis, ( 0px from top )
  • H4 : Narrowing the hunt for nanoparticles, ( 0px from top )
  • H2 : Companies, ( 0px from top )
  • H3 : Company A-Z », ( 0px from top )
  • H3 : Products & Services », ( 0px from top )
  • H3 : Press Releases », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Videos », ( 0px from top )
  • H3 : Suppliers, ( 0px from top )
  • H4 : Lablabo - Airless Metering Pumps for the Pharmaceutical Industry, ( 0px from top )
  • H3 : Suppliers, ( 0px from top )
  • H4 : Labworks International Inc. - Environment Controlled Rooms, Cleanrooms, ICH Stability Chambers, Freezers, and Coolers for Temperature-Sensitive Pharmaceutical and Medical Products, ( 0px from top )
  • H3 : Suppliers, ( 0px from top )
  • H4 : Reliability and Maintenance Services Ltd - ISO17025 Accredited Calibration Services for Temperature, Humidity, and Pressure Instrumentation, ( 0px from top )
  • H3 : Suppliers, ( 0px from top )
  • H4 : tricumed Medizintechnik - Implantable Infusion Pumps to Treat Spasticity and Chronic Pain, ( 0px from top )
  • H2 : All Sections, ( 0px from top )
  • H3 : Projects », ( 0px from top )
  • H3 : Analysis », ( 0px from top )
  • H3 : Company A-Z », ( 0px from top )
  • H3 : Products & Services », ( 0px from top )
  • H3 : News », ( 0px from top )
  • H3 : Press Releases », ( 0px from top )
  • H3 : White Papers », ( 0px from top )
  • H3 : Comment », ( 0px from top )
  • H3 : Research Reports », ( 0px from top )
  • H3 : Advertise With Us », ( 0px from top )
  • H3 : Report Store », ( 0px from top )
  • H3 : About us », ( 0px from top )
  • H3 : Headlines, ( 0px from top )
  • H4 : Pharma Technology Focus – Issue 60, ( 0px from top )
  • H4 : Counting the cost of failure in drug development, ( 0px from top )
  • H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 0px from top )
  • H4 : Boehringer Ingelheim China Biopharmaceuticals Project, Shanghai, ( 0px from top )
  • H2 : Pharmaceutical Insights », ( 0px from top )
  • H3 : Pooling resources for clinical trials, ( 0px from top )
  • H3 : Are cheap Canadian drugs a solution to US pricing issues?, ( 0px from top )
  • H3 : BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial, ( 0px from top )
  • H2 : Pharmaceutical Industry Reports », ( 0px from top )
  • H4 : Glioblastoma: could Zika virus offer new treatment options?, ( 0px from top )
  • H4 : Diagnosed incident cases of cystic fibrosis are set to decrease, ( 0px from top )
  • H4 : China and infectious disease: the one to watch?, ( 0px from top )
  • H4 : Report: Chronic obstructive pulmonary disease market to reach $14.1bn by 2025, ( 0px from top )
  • H2 : Today's Top Stories, ( 156px from top )
  • H1 : Pharma Technology Focus – Issue 60, ( 374px from top )
  • H1 : Counting the cost of failure in drug development, ( 498px from top )
  • H1 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 614px from top )
  • H1 : Boehringer Ingelheim China Biopharmaceuticals Project, Shanghai, ( 784px from top )
  • H2 : Hot Topics, ( 938px from top )
  • H4 : Counting the cost of failure in drug development, ( 997px from top )
  • H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 1079px from top )
  • H4 : Pooling resources for clinical trials, ( 1182px from top )
  • H4 : Are cheap Canadian drugs a solution to US pricing issues?, ( 1243px from top )
  • H2 : Comment & Analysis », ( 1335px from top )
  • H2 : Pharma Technology Focus – Issue 60, ( 1401px from top )

 Typos

harmaceutical-technology.com, poharmaceutical-technology.com, oharmaceutical-technology.com, plharmaceutical-technology.com, lharmaceutical-technology.com, p0harmaceutical-technology.com, 0harmaceutical-technology.com, p-harmaceutical-technology.com, -harmaceutical-technology.com, pharmaceutical-technology.com, harmaceutical-technology.com, p_harmaceutical-technology.com, _harmaceutical-technology.com, parmaceutical-technology.com, phbarmaceutical-technology.com, pbarmaceutical-technology.com, phgarmaceutical-technology.com, pgarmaceutical-technology.com, phtarmaceutical-technology.com, ptarmaceutical-technology.com, phyarmaceutical-technology.com, pyarmaceutical-technology.com, phuarmaceutical-technology.com, puarmaceutical-technology.com, phjarmaceutical-technology.com, pjarmaceutical-technology.com, phmarmaceutical-technology.com, pmarmaceutical-technology.com, phnarmaceutical-technology.com, pnarmaceutical-technology.com, phrmaceutical-technology.com, phaqrmaceutical-technology.com, phqrmaceutical-technology.com, phawrmaceutical-technology.com, phwrmaceutical-technology.com, phazrmaceutical-technology.com, phzrmaceutical-technology.com, pharmaceutical-technology.com, phrmaceutical-technology.com, phaxrmaceutical-technology.com, phxrmaceutical-technology.com, phasrmaceutical-technology.com, phsrmaceutical-technology.com, phamaceutical-technology.com, pharemaceutical-technology.com, phaemaceutical-technology.com, phardmaceutical-technology.com, phadmaceutical-technology.com, pharfmaceutical-technology.com, phafmaceutical-technology.com, phargmaceutical-technology.com, phagmaceutical-technology.com, phar4,maceutical-technology.com, pha4,maceutical-technology.com, phartmaceutical-technology.com, phatmaceutical-technology.com, phar5maceutical-technology.com, pha5maceutical-technology.com, pharaceutical-technology.com, pharmnaceutical-technology.com, pharnaceutical-technology.com, pharmhaceutical-technology.com, pharhaceutical-technology.com, pharmaceutical-technology.com, pharaceutical-technology.com, pharmjaceutical-technology.com, pharjaceutical-technology.com, pharmkaceutical-technology.com, pharkaceutical-technology.com, pharmlaceutical-technology.com, pharlaceutical-technology.com, pharm aceutical-technology.com, phar aceutical-technology.com, pharmceutical-technology.com, pharmaqceutical-technology.com, pharmqceutical-technology.com, pharmawceutical-technology.com, pharmwceutical-technology.com, pharmazceutical-technology.com, pharmzceutical-technology.com, pharmaceutical-technology.com, pharmceutical-technology.com, pharmaxceutical-technology.com, pharmxceutical-technology.com, pharmasceutical-technology.com, pharmsceutical-technology.com, pharmaeutical-technology.com, pharmacxeutical-technology.com, pharmaxeutical-technology.com, pharmacseutical-technology.com, pharmaseutical-technology.com, pharmaceutical-technology.com, pharmaeutical-technology.com, pharmacdeutical-technology.com, pharmadeutical-technology.com, pharmacfeutical-technology.com, pharmafeutical-technology.com, pharmacveutical-technology.com, pharmaveutical-technology.com, pharmac eutical-technology.com, pharma eutical-technology.com, pharmacutical-technology.com, pharmacewutical-technology.com, pharmacwutical-technology.com, pharmacesutical-technology.com, pharmacsutical-technology.com, pharmaceutical-technology.com, pharmacutical-technology.com, pharmacedutical-technology.com, pharmacdutical-technology.com, pharmacefutical-technology.com, pharmacfutical-technology.com, pharmacerutical-technology.com, pharmacrutical-technology.com, pharmace3utical-technology.com, pharmac3utical-technology.com, pharmace4utical-technology.com, pharmac4utical-technology.com, pharmacetical-technology.com, pharmaceuytical-technology.com, pharmaceytical-technology.com, pharmaceuhtical-technology.com, pharmacehtical-technology.com, pharmaceujtical-technology.com, pharmacejtical-technology.com, pharmaceuktical-technology.com, pharmacektical-technology.com, pharmaceuitical-technology.com, pharmaceitical-technology.com, pharmaceu7tical-technology.com, pharmace7tical-technology.com, pharmaceu8tical-technology.com, pharmace8tical-technology.com, pharmaceuical-technology.com, pharmaceutrical-technology.com, pharmaceurical-technology.com, pharmaceutfical-technology.com, pharmaceufical-technology.com, pharmaceutgical-technology.com, pharmaceugical-technology.com, pharmaceuthical-technology.com, pharmaceuhical-technology.com, pharmaceutyical-technology.com, pharmaceuyical-technology.com, pharmaceut5ical-technology.com, pharmaceu5ical-technology.com, pharmaceut6ical-technology.com, pharmaceu6ical-technology.com, pharmaceutcal-technology.com, pharmaceutiucal-technology.com, pharmaceutucal-technology.com, pharmaceutijcal-technology.com, pharmaceutjcal-technology.com, pharmaceutical-technology.com, pharmaceutcal-technology.com, pharmaceutilcal-technology.com, pharmaceutlcal-technology.com, pharmaceutiocal-technology.com, pharmaceutocal-technology.com, pharmaceuti8cal-technology.com, pharmaceut8cal-technology.com, pharmaceuti9cal-technology.com, pharmaceut9cal-technology.com, pharmaceuti*cal-technology.com, pharmaceut*cal-technology.com

More Sites

  • Title: Apopka Furniture Cleaning |Florida Furniture Cleaners
  • Description: Apopka Furniture Cleaning Apopka. Furniture Cleaners Apopka, FL. Online SPECIALS! (407)920-8754. Amazing Results! Furniture Cleaners (Sofa, Love Seat, Sectional Couch, Chair, Ottoman) & FREE guarantee! 32117 32125
  • Internet Protocol (IP) address: 184.168.39.1
  • Tech:
    • CMS
      • Wordpress CMS
    • Analytic
      • Google Analytics
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Javascript
  • Title: freepriceguide.com
  • Description: freepriceguide.com
  • Internet Protocol (IP) address: 184.168.221.104
  • Tech:
    • Advertisement
      • Google Adsense
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Javascript
  • Title:
  • Description:
  • Internet Protocol (IP) address: 54.221.235.173
  • Tech:
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Javascript
  • Title: Tennis-Senioren - Die Community der Tennis-Turnierspieler
  • Description: Wir organisieren Reisen zu den Top-Events. Wir geben Anreise- und Übernachtungs-Tipps zu den Turnieren. Wir tauschen uns aus und bilden Fahrgemeinschaften.
  • Internet Protocol (IP) address: 85.13.139.30
  • Tech:
    • CMS
      • Wordpress CMS
    • Analytic
      • Clicky Web Analytics
      • Google Analytics
    • Advertisement
      • Google Adsense
    • CDN
      • BootstrapCDN
      • Maxcdn
    • Other
      • Carousel
      • CSS (Cascading Style Sheets)
      • Font Awesome
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
      • jQuery
      • Php (Hypertext Preprocessor)
      • Pingback
      • SVG (Scalable Vector Graphics)
  • Title: Foothold Foundation – Providing support and reinforcement to propel collaboration in the social sector.
  • Description:
  • Sites loading time: 5215
  • Internet Protocol (IP) address: 64.64.20.194
  • Javascript total size: 447.74KB
  • CSS total size: 327.06KB
  • Image total size: 803.27KB
  • Total size: 1.86MB
  • Tech:
    • CMS
      • Wordpress CMS
    • Analytic
      • Google Analytics
    • CDN
      • BootstrapCDN
      • Maxcdn
    • Other
      • CSS (Cascading Style Sheets)
      • Flexslider
      • Font Awesome
      • Google Font API
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
      • jQuery
      • jQuery Fancybox
      • Php (Hypertext Preprocessor)
      • Pingback
      • SuperFish
      • SVG (Scalable Vector Graphics)
  • Title: Спортлайн клаб боулинг
  • Description:
  • Sites loading time: 2748
  • Internet Protocol (IP) address: 37.200.71.245
  • Javascript total size: 220.04KB
  • CSS total size: 113.00KB
  • Image total size: 3.37MB
  • Total size: 3.95MB
  • Tech:
    • Other
      • CSS (Cascading Style Sheets)
      • Google Font API
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
      • SVG (Scalable Vector Graphics)
      • Yandex.Metrika
  • Title: sportsinjurydoctor.com
  • Description:
  • Sites loading time: 918
  • Internet Protocol (IP) address: 185.53.179.6
  • Javascript total size: 64.27KB
  • CSS total size: 960.00B
  • Image total size: 42.78KB
  • Total size: 122.58KB
  • Tech:
    • Analytic
      • Google Analytics
    • Advertisement
      • Google Adsense
    • CDN
      • CloudFront
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Javascript
      • Php (Hypertext Preprocessor)
  • Title: DPR Realty, LLC.
  • Description:
  • Internet Protocol (IP) address: 50.28.107.251
  • Tech:
    • Analytic
      • Facebook Retargeting
    • CDN
      • CloudFlare
    • Social
      • Facebook Box
    • Other
      • AJAX Libraries API
      • CSS (Cascading Style Sheets)
      • Google Font API
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
  • Title: Bitnami: Open Source. Simplified
  • Description:
  • Sites loading time: 1147
  • Internet Protocol (IP) address: 40.69.187.85
  • Javascript total size: 0.00B
  • CSS total size: 0.00B
  • Image total size: 97.37KB
  • Total size: 98.06KB
  • Tech:
    • Social
      • Facebook Like button
      • Google +1 Button
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Iframe
      • Javascript
      • PageSpeed Module
      • Php (Hypertext Preprocessor)
      • SVG (Scalable Vector Graphics)
  • Title: Gearhead Water and Powersports - St. Cloud | (407) 915-4838
  • Description: Gearhead Water and Powersports has been serving up fun on the water in St. Cloud, FL since 2006.
  • Internet Protocol (IP) address: 104.31.67.186
  • Tech:
    • CMS
      • Wordpress CMS
    • Other
      • CSS (Cascading Style Sheets)
      • Font Awesome
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
      • jQuery
      • jQuery Colorbox
      • Php (Hypertext Preprocessor)
      • Pingback
      • Shortcodes
      • SuperFish